Duodenal ReCET Plus Semaglutide Can Prevent Need for Insulin in T2DM

THURSDAY, Oct. 24, 2024-- For patients with type 2 diabetes (T2D), duodenal recellularization via electroporation therapy (ReCET), which uses pulsed electric fields to induce natural cell death through an apoptosis-like process, is feasible and...